Premium
Over‐expression of hepatocyte growth factor in human Kaposi's sarcoma
Author(s) -
Maier Jeanette A. M.,
Mariotti Massimo,
Albini Adriana,
Comi Paola,
Prat Maria,
Comoglio Paolo M.,
Soria Marco R.
Publication year - 1996
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/(sici)1097-0215(19960117)65:2<168::aid-ijc7>3.0.co;2-x
Subject(s) - hepatocyte growth factor , sarcoma , cancer research , hepatocyte , medicine , biology , pathology , virology , genetics , in vitro , receptor
Kaposi's sarcoma is a highly vascularized multifocal tumor which frequently appears as a complication of HIV infection. It has been suggested that a disorder in the cytokine network may contribute to the development of the disease. We examined the expression of several cytokines in human sporadic Kaposi's sarcoma specimens, as well as in spindle cells cultured from human lesions, and consistently found high levels of expression of hepatocyte growth factor (HGF). In addition, human lesion‐derived spindle cells synthesize and secrete biologically active hepatocyte growth factor and express the hepatocyte‐growth‐factor receptor (c‐MET). Moreover, elevated levels of transforming growth factor β1 (TGFβ1) mRNA were found in lesions of human sporadic Kaposi's sarcoma and in lesion‐derived spindle cells which also over‐express urokinase. Since HGF, TGFβ1 and urokinase are all involved in capillary‐vessel organization, dysregulation of these interacting agents may play a role in the initiation and/or progression of Kaposi's sarcoma, stimulating the growth of spindle cells and recruiting endothelial cells into the lesion. © 1996 Wiley‐Liss, Inc.